Emcure Pharmaceuticals Limited — Others, 09-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Emcure Pharmaceuticals has announced a confirmation from its Registrar and Share Transfer Agent that all securities received for dematerialisation during the quarter were processed—either accepted or rejected—and updated in the company’s register within prescribed timelines. This ensures proper record of ownership transfer and maintains orderly listing of shares on stock exchanges. The update reflects the company’s ongoing compliance in managing securities and supports transparency for shareholders.